Document Detail


Sevikar: combination therapy for the treatment of hypertension.
MedLine Citation:
PMID:  19129998     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Hypertension is a highly prevalent disease and one of the most important modifiable risk factors for cardiovascular disease. Hypertension remains the leading cause of mortality and the third largest cause of disability in both developed and developing countries. Although recent guidelines and advisory statements are recommending lower thresholds and goals for antihypertensive treatment, approximately two thirds of patients do not achieve the goals. In the United States only 36.8% of hypertensive patients achieve the goal of <140/90 mmHg. Poor adherence to antihypertensive medication regimens contributes to the practice-outcome gap. In most hypertensive patients it is difficult or impossible to control blood pressure with one drug, thus current guidelines have recommended the use of combination therapy as first-line treatment, or early in the management of hypertension. Blocking two or more blood pressure regulatory systems provides a more effective and more physiologic reduction in blood pressure. Fixed-dose combinations offer many advantages over free-drug combinations, such as convenience of use, fewer adverse events, and greater antihypertensive potency. Similar to other combinations, fixed-dose combination tablets containing the dihydropyridine calcium channel blocker amlodipine and the angiotensin receptor blocker olmesartan bring together two distinct and complementary mechanisms of action, resulting in improved blood pressure control and potential for improved target organ protection relative to either class of agent alone.
Authors:
Eduardo Pimenta
Related Documents :
11814138 - Improving the managed care of hypertension with angiotensin ii antagonists.
11777678 - Elevated blood pressure among u.s. adults with diabetes, 1988-1994.
20059368 - Treatment of osteoarthritis in hypertensive patients.
1826478 - Hypertensive heart disease in african-americans.
8320928 - Membrane biocompatibility: effects on cardiovascular stability in patients on hemofiltr...
17490468 - Use of laryngeal mask airway compared to endotracheal tube with positive-pressure venti...
Publication Detail:
Type:  Journal Article     Date:  2009-01-07
Journal Detail:
Title:  Advances in therapy     Volume:  26     ISSN:  1865-8652     ISO Abbreviation:  Adv Ther     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-02-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8611864     Medline TA:  Adv Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1-11     Citation Subset:  T    
Affiliation:
Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, SP, Brazil. espimenta@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk.
Next Document:  Stroke and depression: clinical features and treatment.